Tilmicosin Phosphate
347 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
347
Total Reports
81
Deaths Reported
2330.0%
Death Rate
Active Ingredients
Tilmicosin Phosphate
Administration Routes
IntramuscularOralSubcutaneousUnknownParenteralCutaneousTopicalIntradermalOphthalmicRespiratory (Inhalation)
Species Affected
Human 208
Cattle 108
Pig 17
Goat 6
Unknown 3
Sheep 3
Rabbit 1
Dog 1
Most Affected Breeds
Unknown 211
Cattle (unknown) 41
Crossbred Bovine/Cattle 24
Pig (unknown) 15
Holstein-Friesian also known as Holstein 15
Aberdeen Angus 11
Cattle (other) 9
Mixed (Cattle) 4
Goat (unknown) 3
Boer 2
Most Reported Reactions
Accidental exposure 190
Unclassifiable adverse event 95
Death 75
Lack of efficacy (bacteria) - NOS 31
Injection site bleeding 28
Injection site pain 27
Injection site swelling 27
Nausea 18
Headache 17
Bad taste 17
Tachycardia 14
Hypertension 14
Outcome Breakdown
Recovered/Normal
118 (42.1%)
Died
78 (27.9%)
Outcome Unknown
65 (23.2%)
Recovered with Sequela
15 (5.4%)
Euthanized
4 (1.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.